 |
 |

Vitamin E Supplementation, Cardiovascular Events, and Cancer
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: The article by the HOPE and HOPE-TOO trial investigators1 concludes that vitamin E supplementation does not prevent cancer or cardiovascular events when used for 7 years. Study patients had preexisting coronary or peripheral artery disease, stroke, or diabetes mellitus plus another cardiovascular disease risk factor, and the mean age was 66 years. Although it is a well-controlled investigation, its primary conclusion does not fit the studys parameters.
Heart disease and cancer are serious age-related chronic degenerative illnesses with multiple physical manifestations resulting from oxidative and other changes that have progressed over decades. Expecting to reverse these chronic degenerative processes in only 7 years with use of a vitamin in patients of this age with known vascular disease and diabetes mellitus is unreasonable.
Complementary modalities should be evaluated using the same evidence-based standards and appropriate design criteria as traditional medicines. Vitamin E may or may not be beneficial . . . [Full Text of this Article]
Robert W. Jarski, PhD
jarski@oakland.edu Complementary Medicine and Wellness Program
Kenneth R. Hightower, PhD
School of Health Sciences Oakland University Rochester, Mich
Michael I. Dangovian, DO
Department of Cardiology William Beaumont Hospital Troy, Mich
RELATED ARTICLES
Vitamin E Supplementation, Cardiovascular Events, and Cancer
Robert M. Richey
JAMA. 2005;294(4):425.
EXTRACT
| FULL TEXT
Vitamin E Supplementation, Cardiovascular Events, and Cancer
Alan R. Gaby
JAMA. 2005;294(4):425.
EXTRACT
| FULL TEXT
Vitamin E Supplementation, Cardiovascular Events, and CancerReply
Eva Lonn
JAMA. 2005;294(4):426.
EXTRACT
| FULL TEXT
Effects of Long-term Vitamin E Supplementation on Cardiovascular Events and Cancer: A Randomized Controlled Trial
The HOPE and HOPE-TOO Trial Investigators
JAMA. 2005;293(11):1338-1347.
ABSTRACT
| FULL TEXT
|